
- Volume 0 0
HIGH RATES OF WARFARIN-RELATED AEs IN NURSING HOMES
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
A retrospective study of nursing home residents in Connecticut revealed that the use of warfarin in the nursing home setting presents substantial safety concerns for patients. During the 12-month study period, 490 nursing home residents received warfarin. The primary outcome was a warfarin-related adverse event (AE). Potential warfarin-related AEs were defined as situations in which the international normalized ratio was noted to be 4.5 or greater, and an error in management was noted, but no injury occurred.
Over the 12-month observation period, 720 warfarin-related AEs and 253 potential warfarin-related AEs were identified. Of the warfarin-related AEs, 625 (87%) were characterized as minor, 82 (11%) were deemed serious, and 13 (2%) were life-threatening or fatal. Overall, 29% of the warfarin-related AEs were judged to be preventable. Errors resulting in preventable events occurred most often at the prescribing and monitoring stages of warfarin management.
Articles in this issue
about 18 years ago
The Facts of Liceabout 18 years ago
compounding HOTLINEabout 18 years ago
can you READ these Rxs?about 18 years ago
can you READ these Rxs?about 18 years ago
WARFARIN-RELATED COMPLICATIONS INCREASE WITH AGEabout 18 years ago
IS NATTOKINASE A NATURAL ALTERNATIVE TO WARFARIN?about 18 years ago
LONG-TERM ASPIRIN USE MAY REDUCE RISK OF SOME CANCERSabout 18 years ago
Embracing and Advocating Change in the Pharmacy Professionabout 18 years ago
Improving Pharmaceutical Care of the Elderly Patient with GERDabout 18 years ago
compounding HOTLINENewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































